Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ryan Kaple

Interventional Cardiology Hackensack, NJ Medical Doctor

NPI 1154580694 CMS profile 908434

30 Prospect Ave, Hackensack, NJ 07601

Open in the dashboard

General payments

$178,045

669 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$101,468 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Ryan Kaple of Hackensack, NJ is reported in the CMS Open Payments database as having received $178,045 across 669 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $101,468 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $52,865 166
2024 General $39,007 117
2023 General $19,903 143
2022 General $35,872 104
2021 General $16,364 58
2020 General $4,456 21
2019 General $9,579 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Kaple
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Ryan Kaple were reported at $52,865. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Ryan Kaple Interventional Cardiology median Middle half National median
2019 $9,579 $1,097 $329–$3,048 $163
2020 $4,456 $473 $161–$1,480 $114
2021 $16,364 $677 $233–$1,827 $132
2022 $35,872 $978 $333–$2,724 $149
2023 $19,903 $1,136 $382–$2,986 $160
2024 $39,007 $1,181 $395–$3,326 $164
2025 $52,865 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $134,123 264 payments
  2. Medtronic, Inc. $17,746 147 payments
  3. Edwards Lifesciences Corporation $16,125 110 payments
  4. Medtronic Vascular, Inc. $5,276 60 payments
  5. Boston Scientific Corporation $1,366 23 payments
  6. Ancora Heart, Inc. $1,140 7 payments
  7. Abiomed $548 17 payments
  8. Siemens Medical Solutions USA, Inc. $241 3 payments
  9. W. L. Gore & Associates, Inc. $217 7 payments
  10. Cardiva Medical, Inc. $193 7 payments
  11. Other $1,069 24 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $80,615 36 payments
  2. Travel and Lodging $42,771 99 payments
  3. Food and Beverage $28,560 518 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $13,350 8 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,750 6 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,000 2 payments
Products named General payments · program years 2019–2025
  1. MITRACLIP Vascular $34,605 31 payments
  2. TRICLIP $33,652 44 payments
  3. MITRACLIP Structural Heart $25,406 48 payments
  4. COREVALVE EVOLUT R $14,691 110 payments
  5. MitraClip System $13,105 18 payments
  6. CARDIOMEMS Structural Heart $7,660 26 payments
  7. CARDIOMEMS Heart failure $7,355 50 payments
  8. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $5,582 7 payments
  9. ADVISOR $5,000 4 payments
  10. Mitra Clip system $4,108 3 payments
  11. Other $16,441 265 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 47 billing codes

Paid by Medicare

$99,627

Medicare's payments for the services billed

Medicare patients

190

Average age 80

Services billed

486

93 women, 97 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 66%
Arthritis 59%
Atrial fibrillation 55%
Diabetes 54%
Chronic kidney disease 49%
Cancer 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

669 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record